PROG Holdings Inc
Change company Symbol lookup
Select an option...
PRG PROG Holdings Inc
CHSTY China High Speed Transmission Equipment Group Co Ltd
TTMZF Datable Technology Corp
WVFC W V S Financial Corp
WHLM Wilhelmina International Inc
SON Sonoco Products Co
VIRX Viracta Therapeutics Inc
PFS Provident Financial Services Inc
LPLA LPL Financial Holdings Inc
MTSI MACOM Technology Solutions Holdings Inc
Go

Financials : Consumer Finance |
Company profile

PROG Holdings, Inc., formerly Aaron's Holdings Company, Inc., is a provider of lease-purchase solutions. The Company has more than 30,000 retail partner locations in approximately 46 states and the District of Columbia, including e-commerce merchants. The Company operates through Progressive Leasing and Vive segments. Progressive Leasing segment provides lease-purchase solutions. Vive segment offers a variety of financing programs originated through third-party federally insured banks to customers of participating merchants and, together with Progressive Leasing, allows the Company to provide retail partners with below-prime customers one source for financing and leasing transactions.

Closing Price
$18.43
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
372,296

10-day average volume:
357,490
372,296

Moderna says Japan regulator has approved partial change to NDA for its omicron-targeting COVID booster

7:14 am ET September 12, 2022 (MarketWatch)
Print

Moderna Inc. said Monday the Japanese regulator has approved a partial change to its new drug application for its omicron-targeting COVID booster, MRNA-1273.214. The approval from the Ministry of Health, Labour and Welfare is based on data from a Phase 2/3 trial in which the booster met all primary endpoints, including superior neutralizing antibody response against omicron compared to the currently approved dose of Spikevax in previously uninfected trial participants. It increased neutralizing antibodies by about eightfold above baseline levels and showed higher antibodies against BA.4 and BA.5, the two variants that are now dominant, compared with Spikevax. Moderna has now received authorization decisions for its omicron-targeting booster in the U.S. Australia, Canada, Europe, Switzerland, South Korea, Taiwan and the U.K. Shares were flat premarket but are down 34% in the year to date, while the S&P 500 has fallen 15%.

-Ciara Linnane

	

(END) Dow Jones Newswires

September 12, 2022 07:14 ET (11:14 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.